Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Share-based Compensation (2021 - 2023)

Historic Share-based Compensation for Silo Pharma (SILO) over the last 6 years, with Q4 2023 value amounting to $1414.0.

  • Silo Pharma's Share-based Compensation fell 9764.81% to $1414.0 in Q4 2023 from the same period last year, while for Sep 2025 it was $9888.0, marking a year-over-year change of. This contributed to the annual value of $14125.0 for FY2023, which is 9094.82% down from last year.
  • According to the latest figures from Q4 2023, Silo Pharma's Share-based Compensation is $1414.0, which was down 9764.81% from $4237.0 recorded in Q3 2023.
  • In the past 5 years, Silo Pharma's Share-based Compensation ranged from a high of $83728.0 in Q1 2021 and a low of $1414.0 during Q4 2023
  • In the last 3 years, Silo Pharma's Share-based Compensation had a median value of $21680.0 in 2022 and averaged $28211.1.
  • Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 4624.38% in 2022, then crashed by 9764.81% in 2023.
  • Over the past 3 years, Silo Pharma's Share-based Compensation (Quarter) stood at $83728.0 in 2021, then dropped by 28.19% to $60122.0 in 2022, then crashed by 97.65% to $1414.0 in 2023.
  • Its last three reported values are $1414.0 in Q4 2023, $4237.0 for Q3 2023, and $4237.0 during Q2 2023.